High Fractional Exhaled Nitric Oxide and Sputum Eosinophils Are Associated with an Increased Risk of Future Virus-induced Exacerbations: A Prospective Cohort Study

Overview

Journal Clin Exp Allergy

Specialty Allergy & Immunology

Date 2017 Apr 9

PMID 28390083

Citations 20

Authors

A Bjerregaard

I A Laing

V Backer

A Sverrild

S-K Khoo

G Chidlow

C Sikazwe

D W Smith

P Le Souef

C Porsbjerg

Affiliations

Soon will be listed here.

Abstract

Background: The major trigger of asthma exacerbations is infection with a respiratory virus, most commonly rhinovirus. Type 2 inflammation is known to be associated with an increased risk of exacerbations in general. Whether type 2 inflammation at baseline increases the risk of future virus-induced exacerbations is unknown.

Objective: To assess whether type 2 inflammation is associated with an increased risk of virus-induced exacerbations of asthma.

Methods: Stable asthmatics had spirometry, skin prick test, measurement of FeNO and sputum induced for differential cell counts. Patients were followed up for 18 months, during which they were assessed at the research unit when they had symptoms of an exacerbation. Nasal swabs collected at these assessments underwent viral detection by PCR.

Results: A total of 81 asthma patients were recruited, of which 22 (27%) experienced an exacerbation during the follow-up period. Of these, 15 (68%) had a respiratory virus detected at exacerbation. Sputum eosinophils >1% at baseline increased the risk of having a subsequent virus-induced exacerbation (HR 7.6 95% CI: 1.6-35.2, P=.010) as did having FeNO >25 ppb (HR 3.4 95% CI: 1.1-10.4, P=.033).

Conclusion And Clinical Relevance: Established type 2 inflammation during stable disease is a risk factor for virus-induced exacerbations in a real-life setting. Measures of type 2 inflammation, such as sputum eosinophils and FeNO, could be included in the risk assessment of patients with asthma in future studies.

Citing Articles

When patient-reported respiratory symptoms shed light on pathophysiology in adult asthma: a cross-sectional study.

Louis G, Petre B, Sousa-Pinto B, Bousquet J, Van Ganse E, Schleich F Sci Rep. 2024; 14(1):29997.

PMID: 39623071 PMC: 11612149. DOI: 10.1038/s41598-024-81745-9.

Type-2 inflammation and lung function decline in chronic airway disease in the general population.

Colak Y, Afzal S, Marott J, Vestbo J, Nordestgaard B, Lange P Thorax. 2024; 79(4):349-358.

PMID: 38195642 PMC: 10958305. DOI: 10.1136/thorax-2023-220972.

Prevalence of acute infection in adults with asthma exacerbation: A systematic review and meta-analysis.

Chen X, Zhang P, Ma Y Ann Thorac Med. 2023; 18(3):132-151.

PMID: 37663878 PMC: 10473064. DOI: 10.4103/atm.atm_422_22.

Resolution of Eosinophilic Pneumonia after Coronavirus Disease 2019 without Systemic Corticosteroids.

Misaki Y, Hayashi Y, Shirata M, Terada K, Yoshizawa A, Sakamoto R Intern Med. 2023; 62(21):3223-3230.

PMID: 37587039 PMC: 10686740. DOI: 10.2169/internalmedicine.1648-23.

A cross-sectional analysis of medical conditions and environmental factors associated with fractional exhaled nitric oxide (FeNO) in women and children from the ISA birth cohort, Costa Rica.

Werthmann D, van Wendel de Joode B, Cuffney M, Reich B, Soto-Martinez M, Corrales-Vargas A Environ Res. 2023; 233:116449.

PMID: 37356534 PMC: 10529647. DOI: 10.1016/j.envres.2023.116449.

References

Zeiger R, Schatz M, Zhang F, Crawford W, Kaplan M, Roth R . Elevated exhaled nitric oxide is a clinical indicator of future uncontrolled asthma in asthmatic patients on inhaled corticosteroids. J Allergy Clin Immunol. 2011; 128(2):412-4. DOI: 10.1016/j.jaci.2011.06.008. View

Ortega H, Liu M, Pavord I, Brusselle G, FitzGerald J, Chetta A . Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med. 2014; 371(13):1198-207. DOI: 10.1056/NEJMoa1403290. View

Juniper E, OByrne P, Guyatt G, Ferrie P, King D . Development and validation of a questionnaire to measure asthma control. Eur Respir J. 1999; 14(4):902-7. DOI: 10.1034/j.1399-3003.1999.14d29.x. View

Jackson D, Makrinioti H, Rana B, Shamji B, Trujillo-Torralbo M, Footitt J . IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med. 2014; 190(12):1373-82. PMC: 4299647. DOI: 10.1164/rccm.201406-1039OC. View

Honkoop P, Loijmans R, Termeer E, Snoeck-Stroband J, van den Hout W, Bakker M . Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: A cluster-randomized trial in primary care. J Allergy Clin Immunol. 2014; 135(3):682-8.e11. DOI: 10.1016/j.jaci.2014.07.016. View

Pavord I, Pizzichini M, Pizzichini E, Hargreave F . The use of induced sputum to investigate airway inflammation. Thorax. 1997; 52(6):498-501. PMC: 1758588. DOI: 10.1136/thx.52.6.498. View

Murray C, Poletti G, Kebadze T, Morris J, Woodcock A, Johnston S . Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax. 2005; 61(5):376-82. PMC: 2111190. DOI: 10.1136/thx.2005.042523. View

Bochkov Y, Grindle K, Vang F, Evans M, Gern J . Improved molecular typing assay for rhinovirus species A, B, and C. J Clin Microbiol. 2014; 52(7):2461-71. PMC: 4097758. DOI: 10.1128/JCM.00075-14. View

Haldar P, Brightling C, Singapuri A, Hargadon B, Gupta S, Monteiro W . Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis. J Allergy Clin Immunol. 2014; 133(3):921-3. DOI: 10.1016/j.jaci.2013.11.026. View

10.

Bjerregaard A, Laing I, Backer V, Sverrild A, Khoo S, Chidlow G . High fractional exhaled nitric oxide and sputum eosinophils are associated with an increased risk of future virus-induced exacerbations: A prospective cohort study. Clin Exp Allergy. 2017; 47(8):1007-1013. PMC: 7162064. DOI: 10.1111/cea.12935. View

11.

Zoltowska A, Lei Y, Fuchs B, Rask C, Adner M, Nilsson G . The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma. Clin Exp Allergy. 2015; 46(3):479-90. DOI: 10.1111/cea.12683. View

12.

Green R, Brightling C, McKenna S, Hargadon B, Parker D, Bradding P . Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet. 2002; 360(9347):1715-21. DOI: 10.1016/S0140-6736(02)11679-5. View

13.

Message S, Laza-Stanca V, Mallia P, Parker H, Zhu J, Kebadze T . Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci U S A. 2008; 105(36):13562-7. PMC: 2528869. DOI: 10.1073/pnas.0804181105. View

14.

Lee W, Kiesner C, Pappas T, Lee I, Grindle K, Jartti T . A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants. PLoS One. 2007; 2(10):e966. PMC: 1989136. DOI: 10.1371/journal.pone.0000966. View

15.

Lee H, Headley M, Loo Y, Berlin A, Gale Jr M, Debley J . Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol. 2012; 130(5):1187-1196.e5. PMC: 4284103. DOI: 10.1016/j.jaci.2012.07.031. View

16.

Davoine F, Cao M, Wu Y, Ajamian F, Ilarraza R, Kokaji A . Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells. J Allergy Clin Immunol. 2008; 122(1):69-77, 77.e1-2. DOI: 10.1016/j.jaci.2008.03.028. View

17.

Nicholson K, Kent J, Ireland D . Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993; 307(6910):982-6. PMC: 1679193. DOI: 10.1136/bmj.307.6910.982. View

18.

Parry D, Busse W, Sukow K, Dick C, Swenson C, Gern J . Rhinovirus-induced PBMC responses and outcome of experimental infection in allergic subjects. J Allergy Clin Immunol. 2000; 105(4):692-8. DOI: 10.1067/mai.2000.104785. View

19.

Calhoun W, Ameredes B, King T, Icitovic N, Bleecker E, Castro M . Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. JAMA. 2012; 308(10):987-97. PMC: 3697088. DOI: 10.1001/2012.jama.10893. View

20.

Durrani S, Montville D, Pratt A, Sahu S, Devries M, Rajamanickam V . Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol. 2012; 130(2):489-95. PMC: 3437329. DOI: 10.1016/j.jaci.2012.05.023. View